SEHK:1919
SEHK:1919Shipping

COSCO SHIPPING Holdings (SEHK:1919): Evaluating Valuation After Lower Revenue and Profit in Q3 Results

COSCO SHIPPING Holdings (SEHK:1919) has just published its unaudited third quarter earnings, showing declines in both revenue and net income for the nine months ending September 30, 2025. Investors are watching these results closely. See our latest analysis for COSCO SHIPPING Holdings. Despite posting softer revenue and profit figures, COSCO SHIPPING Holdings has maintained some positive momentum, with a 1-month share price return of nearly 12% and a 1-year total shareholder return of over...
SEHK:2256
SEHK:2256Biotechs

Abbisko Cayman (SEHK:2256): Assessing Valuation Following Key Phase II Oncology Trial Milestone

Abbisko Cayman (SEHK:2256) just kicked off a Phase II trial for its oral PD-L1 inhibitor, ABSK043, combined with Glecirasib. The trial targets non-small cell lung cancer patients with the KRAS G12C mutation. See our latest analysis for Abbisko Cayman. Abbisko Cayman's launch of its latest clinical trial comes after a remarkable period for shareholders. The 1-year total shareholder return is an impressive 237.82%, while the stock has more than tripled year-to-date. The momentum has been...
SEHK:1801
SEHK:1801Biotechs

3 Asian Stocks Estimated To Be Trading At Discounts Up To 39.2%

As global markets navigate a complex landscape marked by mixed performances and geopolitical developments, Asia's stock markets present intriguing opportunities for investors. With Japan's record highs and China's cautious optimism amid trade discussions, identifying undervalued stocks becomes crucial in capitalizing on potential market inefficiencies. In this context, understanding the fundamentals that make a stock undervalued—such as strong financial health, growth potential, and favorable...
SEHK:968
SEHK:968Semiconductor

Asian Market Insights: Zhejiang Taimei Medical Technology Among 3 Compelling Penny Stocks

The Asian markets have been closely watched as global economic dynamics shift, with the recent U.S.-China trade truce providing a temporary boost to investor sentiment. In this context, penny stocks, though often overlooked, can present intriguing opportunities when they exhibit robust financial health. These smaller or newer companies hold potential for growth and value that larger firms might not offer, and we will explore three such compelling stocks in the Asian market.
SEHK:2338
SEHK:2338Machinery

Top Asian Dividend Stocks To Watch In November 2025

As global markets navigate a complex landscape of interest rate adjustments and trade negotiations, Asian markets are also experiencing notable developments. With Japan's stock markets reaching record highs and China focusing on domestic demand to bolster growth, investors are increasingly interested in dividend stocks as a potential source of steady income amidst these shifting economic conditions. A good dividend stock often combines reliable payouts with the ability to adapt to evolving...
SEHK:2517
SEHK:2517Consumer Retailing

Evaluating Guoquan Food (SEHK:2517): Is the Current Valuation Justified After Rapid Q3 Expansion and Profit Growth?

Guoquan Food (Shanghai) SEHK:2517 expanded its retail network by 98% in Q3 2025, adding more than 360 new instant retail stores. This surge aligns with marked gains in year-on-year revenue and core operating profit. See our latest analysis for Guoquan Food (Shanghai). After Guoquan Food’s rapid rollout of new stores and jump in core profit, momentum is clearly building as its share price climbed nearly 20% over the past month with a year-to-date share price return of 106%. In total,...
SEHK:3692
SEHK:3692Pharmaceuticals

Does Regulatory Progress for RET Inhibitor Reshape the Oncology Pipeline Momentum at Hansoh (SEHK:3692)?

The board of directors of Hansoh Pharmaceutical Group announced that China's National Medical Products Administration has accepted the New Drug Application for HS-10365 capsules, a selective RET inhibitor for treating adult patients with RET fusion-positive locally advanced or metastatic non-small cell lung cancer. This regulatory milestone not only reflects progress in Hansoh’s oncology pipeline, but also highlights the company’s potential to address significant unmet needs in lung cancer...
SEHK:1286
SEHK:1286Machinery

A Look at Impro Precision Industries (SEHK:1286) Valuation Following Strong Q3 Revenue Growth and Momentum

Impro Precision Industries (SEHK:1286) just posted a strong year-on-year jump in third quarter revenue, with standout gains in its diversified industrials and AI-related segments. The company’s positive sales outlook continues to draw attention from investors. See our latest analysis for Impro Precision Industries. Momentum has clearly shifted in Impro Precision Industries’ favor, with the share price climbing 12.87% over the past month and surging 65% in the last quarter. That is part of a...